Biology of breast cancer in young women
Open Access
- 27 August 2014
- journal article
- review article
- Published by Springer Science and Business Media LLC in Breast Cancer Research
- Vol. 16 (4), 1-9
- https://doi.org/10.1186/s13058-014-0427-5
Abstract
Breast cancer arising at a young age is relatively uncommon, particularly in the developed world. Several studies have demonstrated that younger patients often experience a more aggressive disease course and have poorer outcome compared to older women. Expression of key biomarkers, including endocrine receptors, HER2 and proliferation markers, appears to be different in younger patients and young women are more likely to harbor a genetic predisposition. Despite these differences, little research to date has focused on the biology of these tumors to refine prognosis, and potentially direct treatment strategies, which remain similar to those offered to older patients. Accumulating evidence suggests the differences in breast stroma in younger patients and changes that occur with pregnancy and breastfeeding likely contribute to the different biology of these tumors. Reproductive behaviors appear to impact the biology of tumors developing later in life. In addition, tumors arising during or shortly following pregnancy appear to exhibit unique biological features. In this review, we discuss our emerging understanding of the biology of breast cancer arising at a young age at both the pathologic and the genomic level. We elucidate the potential role of genomic signatures, the impact of pregnancy and breastfeeding on breast cancer biology, and how even current knowledge might advance the clinical management of young breast cancer patients.Keywords
This publication has 62 references indexed in Scilit:
- Case Control Study of Women Treated With Chemotherapy for Breast Cancer During Pregnancy as Compared With Nonpregnant Patients With Breast CancerThe Oncologist, 2013
- Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus StatementAnnals of Oncology, 2013
- Targeting RANKL in breast cancer: bone metastasis and beyondExpert Review of Anticancer Therapy, 2013
- Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozoleAnnals of Oncology, 2013
- CHEK2*1100delC Heterozygosity in Women With Breast Cancer Associated With Early Death, Breast Cancer–Specific Death, and Increased Risk of a Second Breast CancerJournal of Clinical Oncology, 2012
- Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20–44 years of ageBreast Cancer Research and Treatment, 2012
- Phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway inhibitionCurrent Opinion in Oncology, 2012
- Prognosis of pregnancy-associated breast cancer: A meta-analysis of 30 studiesCancer Treatment Reviews, 2012
- Understanding the biology of triple-negative breast cancerAnnals of Oncology, 2012
- Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersBreast Cancer Research, 2012